00010967529/302024FYFALSEiso4217:USDxbrli:shares00010967522023-10-012024-09-3000010967522024-03-3100010967522024-10-31

美国

证券和交易委员会

华盛顿特区 20549

____________________________________

表格 10-K/A

(修订版 1)

☒			根据1934年证券交易法第13或15（d）条款的年度报告

截至财政年度结束的2024年9月30日

or

☐			根据1934年证券交易法第13或15(d)节的转型报告书

 对于从_______________到_______________的过渡期

委员会文件号 001-15401

益泰威个人护理公司

(根据其章程规定的注册人准确名称)

密苏里

43-1863181

（设立或组织的其他管辖区域）

（美国国税局雇主识别号码）

6研究驱动

(203)

944-5500

Shelton,

康涅狄格州

06484

(注册人电话号码，包括区号)

（总部地址及邮政编码）

在法案第12(b)条的规定下注册的证券：

每个类别的标题			股票标的			在其上注册的交易所的名称
普通股，每股面值$0.01			纽交所			纽约证券交易所

根据该法案第12（g）条登记的证券：无。

标的标记，如果注册人是根据证券法规405条规定的知名老手发行人，请打钩。是 ☒否☐

如果注册人不需要根据《法案》第13或15(d)条提交报告，请用勾号标记。 是 ☐ No ☒

请用勾号勾选以下内容：（1）在过去的12个月内（或者c注册人所需要提交此类报告的更短期限内），c注册人已经提交了根据1934年证券交易法第13或第15（d）条规定需要提交的全部报告；和（2）c注册人在过去的90天内一直需要遵守此类提交要求。是 ☒否☐

请勾选是否注册人已经按照《规则405》的规定，在过去12个月（或注册人被要求提交和发布这些文件的较短时间内）电子提交并在其公司网站上发布了所有必需的互动数据文件。 是 ☒否☐

---

请勾选标记以说明注册人是大型快速申报人、加速申报人、非加速申报人、较小的报告公司还是新兴成长型公司。请查看《交易所法》第120亿.2条中“大型快速申报人”、“加速申报人”、“较小的报告公司”和“新兴成长型公司”的定义。

大型加速报告人

☒

加速文件提交人

☐

非加速文件提交人

☐

（如果是较小的报告公司，请勿选中）

较小的报告公司

☐

新兴成长公司

☐

如果是新兴增长企业，请勾选是否选择不使用扩展过渡期，在符合交易所法第13(a)条规定的任何新的或修订的财务会计准则的合规方面遵循。☐

请勾选标记，以指示注册人是否已提交了《Sarbanes-Oxley法案》(15 U.S.C. 7262(b))下其内部控制的有效性的管理评估报告和证明报告，由准备或发布其审计报告的注册公共会计师事务所编制。☒

如果证券根据《证券法》第12(b)条登记，请勾选印记，以表示注册人包括在文件中的财务报表反映了对之前发布的财务报表的更正。☐

标明任何这些错误更正是否属于重新陈述，是否要求对注册人在有关恢复期间执行的任何高层管理人员激励性报酬进行恢复分析。 ☐

请在 ☐ 中打勾，表示报告人不是壳公司（根据《法案第12b-2条款》的定义）。☐ 否 ☒

截至2024年3月31日，即注册公司最近完成的第二个财政季度的最后一天，非关联方持有的有投票权和无投票权普通股的总市值为$1,871,912,250.

 

截至2024年10月31日，登记公司的普通股流通数量为 48,721,170.

 

参考文件被引用

在2024年股东年会上，注册人的最终代理声明的某些部分将在2024年9月30日之后的120天内向证券交易委员会提交，并通过引用纳入本报告的第三部分。

---

说明注释

Edgewell个人护理公司（可以称为“公司”，“我们”，“我们”和“我们的”）正在提交《年度报告第1号修正案》，对我们截至2024年9月30日的《年度报告10-K表格》的第15项和展览索引进行修正，该报告最初于2024年11月14日提交给美国证券交易委员会（“SEC”，即“原始10-K表格”），仅以包含第10.44、19.1、97.1和104号附件，这些附件在原始10-K表格中不小心遗漏，并根据1934年证券交易法修正案（“交易法”）第120亿.15条款提交我们首席执行官和首席财务官的新认证作为第31.3和31.4号附件。

除非另有规定，在此修改案中，本修改仍然适用于原始10-k表格的日期，并且公司尚未更新其中包含的披露以反映原始10-k表格日期之后发生的任何事件。因此，应与原始10-k表格以及我们向证券交易委员会提交的后续申报书一起阅读。所有在此处使用但未定义的大写词汇应具有其在原始10-k表格中赋予的含义。

项目 15. 陈列品，财务报表附表。

作为本报告的一部分提交的文件：

1)基本报表。

以下内容包括在原始10-k表格的第8条。基本报表和补充数据。

◦独立注册会计师事务所的报告 普华永道会计师事务所 在 康涅狄格州斯坦福德 （PCAOB ID 238).

◦2024年，2023年和2022年截至9月30日的综合收益和综合收益综合表。

◦截至2024年和2023年9月30日的合并资产负债表。

◦截至2024年、2023年和2022年9月30日的合并现金流量表。

◦2021年10月1日至2024年9月30日股东权益变动表。

◦基本报表附注。

2)财务报表附表。

附表二 - 估值和合格账户包含在原始10-K表的项目15. 基本报表和补充数据中。

3)附件。

1

---

附件描述

展览编号			展览
2.1****			公司与energizer holdings, inc.之间的分拆和分配协议日期为2015年6月25日（参见提交于2015年6月29日的公司第8-k表格上的附件2.1）
2.2****			公司与energizer holdings, inc.之间的税务事项协议日期为2015年6月26日（参见提交于2015年6月29日的公司第8-k表格上的附件2.2）
2.3****			公司与energizer holdings, inc.之间的员工事项协议日期为2015年6月25日（参见提交于2015年6月29日的公司第8-k表格上的附件2.3）
2.4****			公司与energizer holdings, inc.之间的过渡服务协议日期为2015年6月25日（参见提交于2015年6月29日的公司第8-k表格上的附件2.4）
2.5****			公司与energizer holdings, inc.之间的出资协议日期为2015年6月30日（参见提交于2015年7月1日的公司第8-k表格上的附件2.1）
2.6			edgewell personal care公司、callahan corp.、harry's inc.和个别作为股东代表的当事人之间的合并协议和计划日期为2019年5月8日（参见提交于2019年5月13日的公司第8-k表格上的附件2.1）
2.7			专门用于第13.17节的edgewell personal care公司的会员权益购买协议，edgewell personal care，LLC，Cremo Holding Company，LLC，其中命名的卖方，以及日期为2020年8月1日的联合持有人代表。
3.1			公司的修订和重置公司章程（依据提交的文档3.1，根据公司截至2013年12月31日季度报告在表格10-Q中的解释）。
3.2			2015年6月30日生效的合并公约（依据提交的文档3.1，根据公司于2015年7月1日提交的表格8-k中的解释）。
3.3			公司的修订和重置公司章程有效日期为2020年11月5日（依据提交的文档3.3，根据公司于2020年11月20日提交的表格10-k中的解释）。
4.1			2011年5月19日生效的债券契约，由公司，其中命名的担保人，以及信托公司纽约梅隆银行，作为受托人签署（根据公司于2011年5月19日提交的表格8-k中的文档4.1）。
4.2			第一份补充债券契约，日期为2011年5月19日，由公司，其中命名的担保人，以及纽约梅隆银行信托公司，N.A.，作为受托人签署（根据公司于2011年5月19日提交的表格8-k中的文档4.2）。
4.3			第二份补充债券契约（包括票据形式），日期为2012年5月24日，由公司，其中命名的担保人，以及纽约梅隆银行信托公司，N.A.，作为受托人签署（根据公司于2012年5月24日提交的表格8-k中的文档4.2）。
10.1			2015年6月1日的授信协议，由公司作为借款人，JPMorgan Chase银行，N.A.作为管理代理人，以及美国银行，N.A.，纽约梅隆银行，东京三菱联合金融银行，有限公司，以及花旗银行，N.A.，作为共同银团代理签署（根据公司于2015年6月1日提交的表格8-k中的文档10.1）。
10.2			关于2015年9月25日日前公司提出的《第1号全案修正案对信贷协议和附属担保做出部分修改》，其中有关方包括借款人Edgewell个人护理公司，新的子公司借款人Edgewell个人护理品牌有限责任公司，Edgewell的若干其他子公司作为附属担保人，摩根大通银行作为行政代理，美国银行，日本三菱东京日联银行及花旗银行作为共同组合代理，以及各方贷款人（参见《2015年9月29日提交的公司第8-k号当前报告附件10.1》）引用组成。
10.3			关于2016年4月29日日前公司提出的《信贷协议第2号修正案对Edgewell个人护理公司等所做修正》中有关方包括借款人Edgewell个人护理公司，子公司借款人Edgewell个人护理品牌有限责任公司，Edgewell个人护理公司的若干其他子公司作为附属担保人，摩根大通银行作为行政代理，以及各方贷款人（参见《2016年4月29日提交的公司第8-k号当前报告附件10.1》）引用组成。
10.4			关于2017年3月13日日前公司提出的《信贷协议第3号修正案》对其中有关方包括借款人Edgewell个人护理公司，子公司借款人Edgewell个人护理品牌有限责任公司，Edgewell个人护理公司的若干其他子公司作为附属担保人，摩根大通银行作为行政代理，美国银行作为联合代理，以及各方贷款人（参见《2017年3月14日提交的公司第8-k号当前报告附件10.1》）引用组成。
10.5			关于2017年3月13日日前公司提出的《增加贷款方补充文件》，其中有关方包括增加贷款方日本三菱东京日联银行，借款人Edgewell个人护理公司，摩根大通银行作为行政代理（参见《2017年3月14日提交的公司第8-k号当前报告附件10.2》）引用组成。

---

10.6			Credit Agreement by and among Edgewell Personal Care Netherlands B.V., as borrower, the Company, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 15, 2015).
10.7			Amendment No. 1 dated as of September 25, 2015 to Credit Agreement by and among Edgewell Personal Care Netherlands B.V., Edgewell Personal Care Company, the institutions listed on the signature pages thereto and the Bank of Tokyo-Mitsubishi UFJ, Ltd., as the administrative agent for the lenders referred to therein (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed September 29, 2015).
10.8			Master Accounts Receivable Purchase Agreement dated as of September 15, 2017 among Edgewell Personal Care, LLC, as the Seller, Edgewell Personal Care Company, as Guarantor, and The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the Purchaser (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed September 19, 2017).
10.9			Sixth Amendment to Master Accounts Receivable Purchase Agreement, dated as of February 7, 2022, between the Company and MUFG Bank, Ltd. (incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2022).
10.10			Seventh Amendment to Master Accounts Receivable Purchase Agreement, dated as of August 5, 2024, between the Company and MUFG Bank, Ltd (incorporated by reference to Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q filed on August 6, 2024).
10.11			Credit Agreement, dated as of March 28, 2020, by and among, inter alia, the Company, the subsidiaries of the Company from time to time parties thereto, the lenders from time to time parties thereto, MUFG, as syndication agent, TD as joint lead arranger and BofA, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 2, 2020).
10.12			Restatement Agreement, dated as of April 2, 2024, among Edgewell Personal Care Company, each of the guarantors party thereto, Bank of America, N.A., as Administrative Agent, the Issuing Bank and each Refinancing Lender party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed April 2, 2024).
10.13			Indenture, dated as of May 22, 2020, among Edgewell Personal Care Company, the guarantors party thereto and the Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed May 22, 2020.
10.14			Indenture, dated as of March 8, 2021, among Edgewell Personal Care Company, the guarantors party thereto and the Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed March 8, 2021).
10.15			Trademark License Agreement by and between the Company and Energizer Brands, LLC dated June 25, 2015 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed June 29, 2015).
10.16			Trademark License Agreement by and between the Company and Wilkinson Sword GmbH, as licensors, and Energizer Holdings, Inc. dated June 25, 2015 (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed June 29, 2015).
10.17			Tax Sharing Agreement (incorporated by reference to Exhibit 2.2 of the Company’s Post-Effective Amendment No. 1 to Form 10, filed April 19, 2000).
10.18***			A Summary of the Company's director compensation program (incorporated by reference to the Company's Definitive Proxy Statement for the fiscal year ended September 30, 2016).
10.19***			Form of Indemnification Agreement (for directors with existing agreements) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 28, 2015).
10.20***			Form of Indemnification Agreement (for new directors) (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed May 28, 2015).
10.21***			Second Amended and Restated 2009 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2013).
10.22***			Form of Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed July 10, 2015).
10.23***			Form of Change of Control Agreement with certain Executive Officers (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 2, 2017).
10.24***			January 1, 2015 Restatement of the Company's Executive Savings Investment Plan (incorporated by reference to Exhibit 10.21 to the Company's Annual Report on Form 10-K for the year ended September 30, 2015).
10.25***			Amendment to the Company's Executive Savings Investment Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.12 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.26***			2010 Restatement of the Company's Supplemental Executive Retirement Plan dated October 15, 2010 (incorporated by reference to Exhibit 10.54 of Amendment No. 1 to the Company's Annual Report on Form 10-K/A, filed May 16, 2011).

---

10.27***			First Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.24 to the Company's Annual Report on Form10-K for the year ended September 30, 2015).
10.28***			Second Amendment to the 2010 Restatement of the Company's Supplemental Executive Retirement Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.13 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.29***			2009 Restatement of the Company's Deferred Compensation Plan, as amended and restated effective as of January 1, 2009 (incorporated by reference to Exhibit 10 of the Company's Annual Report on Form 10-K for the year ended September 30, 2008).
10.30***			First Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 4.3 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.31***			Amendment No. 2 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 4.4 to the Company's Registration Statement on Form S-8 filed November 21, 2012).
10.32***			Amendment No. 3 to 2009 Restatement of the Company's Deferred Compensation Plan, dated November 7, 2011 (incorporated by reference to Exhibit 10.59 to the Company's Annual Report on Form 10-K for the year ended September 30, 2012).
10.33***			Amendment No. 4 to the 2009 Restatement of the Company's Deferred Compensation Plan (incorporated by reference to Exhibit 10.60 to the Company's Annual Report on Form 10-K for the year ended September 30, 2012).
10.34***			Amendment to the 2009 Restatement of the Company's Deferred Compensation Plan, effective July 1, 2015 (incorporated by reference to Exhibit 10.14 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2015).
10.35***			Executive Group Personal Excess Liability Insurance Plan (incorporated by reference to Exhibit 10.9 of the Company's Post-Effective Amendment No. 1 to Form 10, filed April 19, 2000).
10.36***			Amended and Restated Executive Officer Bonus Plan (incorporated by reference to Exhibit 10.36 to the Company's Annual Report on Form 10-K for the year ended September 30, 2016).
10.37***			2017 Edgewell Personal Care Company Financial Planning Plan (incorporated by reference to Exhibit 10.39 to the Company's Annual Report on Form 10-K for the year ended September 30, 2017.
10.38***			Edgewell Personal Care Company Executive Severance Plan (incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2017).
10.39***			Edgewell Personal Care Company Change in Control Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed May 1, 2019).
10.40***			Separation and General Release Agreement entered into on October 6, 2023 by and between John N. Hill and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed October 11, 2023).
10.41***			Separation and General Release Agreement entered into on July 31, 2024 by and between Eric O'Toole and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 6, 2024).
10.42***			Employment Offer Letter, dated November 7, 2024 by and between Francesca Weissman and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.42 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
10.43***			Employment Offer Letter, dated October 31, 2024 by and between Daniel Sullivan and Edgewell Personal Care Company (incorporated by reference to Exhibit 10.43 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
10.44*/***			Edgewell Personal Care Company 2nd Amended and Restated 2018 Stock Incentive Plan
19.1*			Edgewell Personal Care Company Insider Trading Policy.
21.1			Subsidiaries of Registrant (incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
23.1			Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 23.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
31.1			Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 31.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
31.2			Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 31.2 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).

---

31.3*			Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4*			Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.1 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
32.2			Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.2 to the Company’s Annual Report on Form 10-K filed on November 14, 2024).
97.1*			Edgewell Personal Care Company Compensation Recovery Policy.
101*			The following materials from the Edgewell Personal Care Company Annual Report on Form 10-K formatted in inline eXtensible Business Reporting Language (iXBRL): (i) the Consolidated Statements of Earnings and Comprehensive Income for the years ended September 30, 2022, 2023 and 2024, (ii) the Consolidated Balance Sheets at September 30, 2023 and 2024, (iii) the Consolidated Statements of Cash Flows for the years ended September 30, 2022, 2023 and 2024, (iv) Consolidated Statements of Changes in Shareholders’ Equity for the period from October 1, 2021 to September 30, 2024, and (v) Notes to Consolidated Financial Statements for the year ended September 30, 2024.
104*			Cover Page Interactive Data File (cover page XBRL tags are embedded within the Inline XBRL document).

 

*Filed herewith.

**Furnished herewith.

***Denotes a management contract or compensatory plan or arrangement.

****The Company hereby undertakes to furnish supplementally a copy of any omitted schedule or exhibit to such agreement to the Securities and Exchange Commission upon request.

---

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			EDGEWELL PERSONAL CARE COMPANY
			By:			/s/ Rod R. Little
						Rod R. Little
						President and Chief Executive Officer

Date: November 21, 2024